共 24 条
Patient Activation Changes as a Potential Signal for Changes in Health Care Costs: Cohort Study of US High-Cost Patients
被引:34
作者:
Lindsay, Ann
[1
]
Hibbard, Judith H.
[2
]
Boothroyd, Derek B.
[3
]
Glaseroff, Alan
[4
]
Asch, Steven M.
[5
]
机构:
[1] Stanford Univ, Sch Med, Dept Med, Div Primary Care & Populat Hlth, 2475 North Bank Rd, Mckinleyville, CA 95519 USA
[2] Univ Oregon, Eugene, OR 97403 USA
[3] Stanford Univ, Dept Med, Sch Med, Quantitat Sci Unit, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Ctr Excellence Clin Res, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Med, Sch Med, VA Ctr Innovat Implementat, Stanford, CA 94305 USA
关键词:
medicare;
patient activation;
health economics;
return on investment;
SELF-MANAGEMENT;
MEASURE PAM;
HIGH-NEED;
OUTCOMES;
LEVEL;
D O I:
10.1007/s11606-018-4657-6
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
BackgroundPrograms to improve quality of care and lower costs for the highest utilizers of health services are proliferating, yet such programs have difficulty demonstrating cost savings.ObjectiveIn this study, we explore the degree to which changes in Patient Activation Measure (PAM) levels predict health care costs among high-risk patients.ParticipantsDe-identified claims, demographic data, and serial PAM scores were analyzed on 2155 patients from multiple medical groups engaged in an existing Center for Medicare and Medicaid Innovation-funded intervention over 3years designed to activate and improve care coordination for high-risk patients.DesignIn this prospective cohort study, four levels of PAM (from low to high) were used as the main predictor variable. We fit mixed linear models for log(10) of allowed charges in follow-up periods in relation to change in PAM, controlling for baseline PAM, baseline costs, age, sex, income, and baseline risk score.Main MeasuresTotal allowed charges were derived from claims data for the cohort. PAM scores were from a separate database managed by the local practices.Key ResultsA single PAM level increase was associated with 8.3% lower follow-up costs (95% confidence interval 2.5-13.2%).ConclusionsThese findings contribute to a growing evidence base that the change in PAM score could serve as an early signal indicating the impact of interventions designed for high-cost, high-needs patients.
引用
收藏
页码:2106 / 2112
页数:7
相关论文